Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 28, 2019
Outcomes of ultrasound-guided percutaneous microwave ablation versus surgical resection for symptomatic large hepatic hemangiomasXiaoyin Tang, Min Ding, Bingwei Lu, et al.Journal of Cancer Research and Therapeutics|July 16, 2021
Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe: A pilot clinical studyYuan Peng, Dan Cui, Weijian Li, et al.Radiology|November 25, 2015
Gliomas: Motexafin Gadolinium-enhanced Molecular MR Imaging and Optical Imaging for Potential Intraoperative Delineation of Tumor MarginsLonghua Qiu, Feng Zhang, Yaoping Shi, et al.The Science of the Total Environment|November 17, 2023
Single-cell transcriptome analysis of liver immune microenvironment changes induced by microplastics in mice with non-alcoholic fatty liverWangrui Liu, Meng Li, Huaqi Guo, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 12, 2018
Oliguric acute kidney injury after microwave ablation of large liver tumors: incidence and preventive measuresMin Ding, Sicong Ma, Xiaoyin Tang, et al.Frontiers in Pharmacology|November 18, 2021
Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapyWeizhen Li, Yang Zhou, Zhongen Wu, et al.Journal of Cancer Research and Clinical Oncology|September 22, 2016
Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factorsSicong Ma, Min Ding, Jiang Li, et al.European Radiology|January 29, 2022
Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matchingJian Kong, Ruize Gao, Shilun Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I TrialsDonghua Shi, Yaoping Shi, Ahmed O Kaseb, et al.Ebiomedicine|December 11, 2022
Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancerYangyang Zhou, Siying Wang, Wei Wu, et al.Pageof 4